Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Stopped The sponsor stopped the study due to low recruitment with no safety concerns

Conditions

• Pneumonia

Interventions

• DRUG: PRISTINAMYCIN XRP7263
• DRUG: Amoxicillin
• DRUG: Amoxicillin Placebo
• DRUG: PRISTINAMYCIN Placebo

Sponsor

Sanofi